Glucotrack regains Nasdaq stockholders’ equity compliance, secures continued listing
GCTK•Nasdaq compliance and continued listing
- GlucoTrack regained compliance with Nasdaq’s stockholders’ equity requirement.
- The Nasdaq Hearings Panel granted the company continued listing on Nasdaq, subject to conditions.
- The decision removes an immediate delisting risk.
